Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)
5.55
+0.19 (3.54%)
Apr 10, 2026, 11:39 AM CST
SHE:300239 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 482.38 | 532.1 | 748.69 | 356.11 | 225.87 |
Cash & Short-Term Investments | 482.38 | 532.1 | 748.69 | 356.11 | 225.87 |
Cash Growth | -9.34% | -28.93% | 110.24% | 57.66% | 370.09% |
Accounts Receivable | 252.85 | 333.81 | 302.92 | 335.79 | 302.47 |
Other Receivables | 1.02 | 1.29 | 1.46 | 3.15 | 5.19 |
Receivables | 253.87 | 335.1 | 304.38 | 338.93 | 307.66 |
Inventory | 401.37 | 354.46 | 281.53 | 317.84 | 346.02 |
Other Current Assets | 10.84 | 12.96 | 15 | 11.01 | 13.04 |
Total Current Assets | 1,148 | 1,235 | 1,350 | 1,024 | 892.59 |
Property, Plant & Equipment | 1,195 | 1,204 | 1,163 | 1,019 | 966.9 |
Long-Term Investments | 19.12 | 21.05 | 24.45 | 28.32 | 34.88 |
Other Intangible Assets | 135.79 | 143.26 | 144.84 | 152.14 | 174.6 |
Long-Term Deferred Tax Assets | 18.2 | 13.02 | 13.65 | 11.84 | 10.67 |
Long-Term Deferred Charges | 3.26 | 2.9 | 6.44 | 4.63 | 9.46 |
Other Long-Term Assets | 29.62 | 6.11 | 40.24 | 68.21 | 23.13 |
Total Assets | 2,550 | 2,625 | 2,742 | 2,308 | 2,112 |
Accounts Payable | 152.18 | 216.07 | 187.32 | 124.79 | 141.59 |
Accrued Expenses | 14.68 | 28.34 | 25.72 | 24.37 | 24.46 |
Short-Term Debt | - | - | 5.84 | 2.07 | 50.52 |
Current Portion of Long-Term Debt | 6.49 | 6.75 | 0.04 | 41.02 | - |
Current Income Taxes Payable | 5.81 | 5.02 | 5.74 | 9 | 4.45 |
Current Unearned Revenue | 7.51 | 9.92 | 7.02 | 14.29 | 4.8 |
Other Current Liabilities | 49.18 | 57.68 | 69.26 | 100.73 | 195.57 |
Total Current Liabilities | 235.85 | 323.77 | 300.94 | 316.26 | 421.39 |
Long-Term Debt | 493.7 | 471.9 | 462.82 | 152 | - |
Long-Term Unearned Revenue | 50.25 | 48.51 | 45.16 | 48.67 | 49.64 |
Long-Term Deferred Tax Liabilities | 36.69 | 31.32 | 29.9 | 25.34 | 27.56 |
Other Long-Term Liabilities | 10 | 10 | 10 | 10 | 10 |
Total Liabilities | 826.49 | 885.5 | 848.82 | 552.26 | 508.58 |
Common Stock | 593.61 | 593.61 | 593.6 | 593.6 | 593.6 |
Additional Paid-In Capital | 644.38 | 644.38 | 635.82 | 635.82 | 635.88 |
Retained Earnings | 516.22 | 476.46 | 403.54 | 299.09 | 193.21 |
Treasury Stock | -56.11 | - | - | - | - |
Comprehensive Income & Other | 25.1 | 25.1 | 25.1 | - | - |
Total Common Equity | 1,723 | 1,740 | 1,658 | 1,529 | 1,423 |
Minority Interest | - | -0.12 | 235.13 | 227.35 | 180.97 |
Shareholders' Equity | 1,723 | 1,739 | 1,893 | 1,756 | 1,604 |
Total Liabilities & Equity | 2,550 | 2,625 | 2,742 | 2,308 | 2,112 |
Total Debt | 500.19 | 478.65 | 468.71 | 195.09 | 50.52 |
Net Cash (Debt) | -17.8 | 53.45 | 279.98 | 161.02 | 175.35 |
Net Cash Growth | - | -80.91% | 73.88% | -8.17% | - |
Net Cash Per Share | -0.03 | 0.08 | 0.46 | 0.27 | 0.31 |
Filing Date Shares Outstanding | 584.58 | 593.61 | 593.6 | 593.6 | 593.6 |
Total Common Shares Outstanding | 584.58 | 593.61 | 593.6 | 593.6 | 593.6 |
Working Capital | 912.6 | 910.86 | 1,049 | 707.64 | 471.21 |
Book Value Per Share | 2.95 | 2.93 | 2.79 | 2.57 | 2.40 |
Tangible Book Value | 1,587 | 1,596 | 1,513 | 1,376 | 1,248 |
Tangible Book Value Per Share | 2.72 | 2.69 | 2.55 | 2.32 | 2.10 |
Buildings | - | 653.56 | 550.38 | 552.09 | 522.11 |
Machinery | - | 823.47 | 647.13 | 640.8 | 612.12 |
Construction In Progress | - | 204.96 | 364.94 | 160.29 | 94.1 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.